NO20020676L - Oral administreringsform som inneholder probiotiske mikroorganismer - Google Patents

Oral administreringsform som inneholder probiotiske mikroorganismer

Info

Publication number
NO20020676L
NO20020676L NO20020676A NO20020676A NO20020676L NO 20020676 L NO20020676 L NO 20020676L NO 20020676 A NO20020676 A NO 20020676A NO 20020676 A NO20020676 A NO 20020676A NO 20020676 L NO20020676 L NO 20020676L
Authority
NO
Norway
Prior art keywords
oral administration
probiotic microorganisms
administration containing
containing probiotic
microorganisms
Prior art date
Application number
NO20020676A
Other languages
English (en)
Other versions
NO20020676D0 (no
Inventor
Joachim Bug
Iris Manneck
Martina Schmid
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20020676D0 publication Critical patent/NO20020676D0/no
Publication of NO20020676L publication Critical patent/NO20020676L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
NO20020676A 1999-08-12 2002-02-11 Oral administreringsform som inneholder probiotiske mikroorganismer NO20020676L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19937361A DE19937361A1 (de) 1999-08-12 1999-08-12 Orale Darreichungsform
PCT/EP2000/006580 WO2001012164A1 (de) 1999-08-12 2000-07-12 Orale darreichungsform enthaltend probiotische mikroorganismen

Publications (2)

Publication Number Publication Date
NO20020676D0 NO20020676D0 (no) 2002-02-11
NO20020676L true NO20020676L (no) 2002-02-11

Family

ID=7917589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020676A NO20020676L (no) 1999-08-12 2002-02-11 Oral administreringsform som inneholder probiotiske mikroorganismer

Country Status (20)

Country Link
EP (1) EP1207859B1 (no)
JP (1) JP2003506481A (no)
KR (1) KR20020031383A (no)
CN (1) CN1364076A (no)
AR (1) AR025020A1 (no)
AT (1) ATE276746T1 (no)
AU (1) AU770792B2 (no)
BR (1) BR0013110A (no)
CA (1) CA2377415A1 (no)
CZ (1) CZ2002354A3 (no)
DE (2) DE19937361A1 (no)
HK (1) HK1048065A1 (no)
HU (1) HUP0203029A3 (no)
MX (1) MXPA02000630A (no)
NO (1) NO20020676L (no)
PL (1) PL353878A1 (no)
RU (1) RU2002105484A (no)
SK (1) SK1632002A3 (no)
WO (1) WO2001012164A1 (no)
ZA (1) ZA200110534B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
DE10206995B4 (de) * 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
ES2368344T3 (es) 2005-05-18 2011-11-16 Dsm Ip Assets B.V. Composiciones para aplicación parenteral de microorganismos.
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
DE202007013316U1 (de) 2007-09-21 2009-02-12 Voss Automotive Gmbh Anschlussvorrichtung für Medienleitungen
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2012021432A2 (en) 2010-08-10 2012-02-16 R.P Scherer Technologies, Llc Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
JP2014189547A (ja) * 2013-03-28 2014-10-06 Lintec Corp 嚥下物被覆体
JP6456377B2 (ja) * 2014-06-10 2019-01-23 ライオン株式会社 清酒酵母を含有する錠剤
EP3344268A1 (en) * 2015-08-31 2018-07-11 Nestec S.A. Methods and compositions using bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances
CN107115311A (zh) * 2017-05-04 2017-09-01 江苏大学 一种双歧杆菌肠溶片及其制备方法
JP2023510158A (ja) * 2019-12-27 2023-03-13 エヴェロ バイオサイエンシズ，インコーポレーテッド 細菌及び微生物細胞外小胞を含有する固形剤形
EP4135670A1 (en) * 2020-04-17 2023-02-22 Evelo Biosciences, Inc. Solid dosage forms with improved disintegration profiles
US11426353B2 (en) * 2020-06-24 2022-08-30 13400719 Canada Inc. Composite coating for an active agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62201823A (ja) * 1986-02-28 1987-09-05 Freunt Ind Co Ltd 腸内有用細菌含有物およびその製造方法
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
JPH0441434A (ja) * 1990-06-07 1992-02-12 Asahi Breweries Ltd 腸溶性コーティングを施した乳酸菌錠剤
JP3083169B2 (ja) * 1991-02-27 2000-09-04 日清製粉株式会社 ビフィズス菌製剤およびその製法
JP3187502B2 (ja) * 1992-01-09 2001-07-11 カネボウ株式会社 腸溶性造粒物
JP2859217B2 (ja) * 1995-08-10 1999-02-17 日清製粉株式会社 腸内有用細菌含有顆粒の製造方法
KR100387245B1 (ko) * 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
JPH11139978A (ja) * 1997-11-06 1999-05-25 Asahi Beer Yakuhin Kk 腸溶性生菌製剤

Also Published As

Publication number Publication date
AU770792B2 (en) 2004-03-04
AU6158100A (en) 2001-03-13
PL353878A1 (en) 2003-12-01
DE50007927D1 (de) 2004-10-28
WO2001012164A1 (de) 2001-02-22
EP1207859A1 (de) 2002-05-29
HK1048065A1 (zh) 2003-03-21
BR0013110A (pt) 2002-05-07
NO20020676D0 (no) 2002-02-11
CZ2002354A3 (cs) 2002-05-15
SK1632002A3 (en) 2002-06-04
ATE276746T1 (de) 2004-10-15
KR20020031383A (ko) 2002-05-01
CN1364076A (zh) 2002-08-14
HUP0203029A3 (en) 2004-10-28
EP1207859B1 (de) 2004-09-22
DE19937361A1 (de) 2001-02-22
ZA200110534B (en) 2003-07-30
CA2377415A1 (en) 2001-02-22
RU2002105484A (ru) 2003-11-20
HUP0203029A2 (hu) 2002-12-28
MXPA02000630A (es) 2002-08-30
AR025020A1 (es) 2002-11-06
JP2003506481A (ja) 2003-02-18

Similar Documents

Publication Publication Date Title
NO20020676L (no) Oral administreringsform som inneholder probiotiske mikroorganismer
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
ZA200202480B (en) Oral dosage forms.
HUP0203204A3 (en) Oral dosage forms
AU1998200A (en) Multiparticulate oral dosage forms
FI991485A0 (fi) Uusi farmaseuttinen koostumus
IS6263A (is) Lyfjasamsetningar, sem innihalda trípeptíð
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
MXPA03004941A (es) Formulacion farmacologica que tiene tolerancia por via oral mejorada.
AU4024100A (en) Anti-caries oral care compositions
ATE264680T1 (de) Beta-carbolin arzneistoffprodukte
DE60045402D1 (de) Silylalkylplatin (IV) Verbindungen und deren Herstellung
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
IL154850A0 (en) Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same
DE69807768D1 (de) Rapamycin enthaltende Formulierungen zur oralen Verabreichung
ID30397A (id) Larutan oral prukaloprida
HUP0201667A2 (en) Oral form of administration
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
GB9923045D0 (en) New oral formulations
HUP0201914A2 (en) Oral care composition
PL1663101T3 (pl) Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie
ITMO990002A0 (it) Articolatore per odontotecnica.
ZA200108206B (en) Oral pharmaceutical ibuprofen suspension.
DE29901073U1 (de) Kippschutz

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application